Sculptor Capital’s Tenet Healthcare THC Stock Holding History

Sculptor Capital’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-302,100	Closed	-$4.96M	–	163
2017 Q3	$4.96M	Buy	+302,100	New	+$5.12M	0.02%	155

Other funds holding THC

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WAM

Warlander Asset Management New York $111M AUM 8.26% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sculptor Capital's THC Position: Q4 2017 in Review

Sculptor Capital sold out of Tenet Healthcare (THC) in Q4 2017, closing a stake of 300,100 shares — an estimated $4.93M sold.

Sculptor Capital first reported a position in THC in Q2 2013 and held it in 4 quarters. The position peaked at $43.8M in Q4 2013. 233 funds tracked by Wall St. Rank hold THC as of Q4 2017.

Sculptor Capital reported no remaining Tenet Healthcare position as of Q4 2017 after selling out during the quarter.
Sculptor Capital sold 300,100 Tenet Healthcare shares in Q4 2017, an estimated $4.93M.
Sculptor Capital first reported a position in Tenet Healthcare in Q2 2013 and held it in 4 quarters.
Sculptor Capital's Tenet Healthcare position peaked at $43.8M in Q4 2013.
233 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2017.

Based on Sculptor Capital's 13F filing for Q4 2017, filed 13 Feb 2018.